DrugNewswire
MONROVIA, Calif., Jan. 24 /PRNewswire-FirstCall/ -- STAAR Surgical Company (NASDAQ:STAA) today announced that it believes a new ruling by the Centers for Medicare and Medicaid Services (CMS), which allows cataract patients covered by Medicare to choose a lens that also corrects astigmatism, will include STAAR's Toric Intraocular Lens.